Health Catalyst slips as RBC Capital Markets downgrades citing hospital headwinds

Oct. 25, 2022 8:55 AM ETHealth Catalyst, Inc. (HCAT)HCA, THCBy: Dulan Lokuwithana, SA News Editor1 Comment

Wall Street sign, New York City, USA

mbbirdy/E+ via Getty Images

Health Catalyst, Inc. (NASDAQ:HCAT) dropped ~7% pre-market Tuesday after RBC Capital Markets lowered its rating on the healthcare software company and slashed its price target to $9 from $19 per share in reaction to challenges

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.